SAB Biotherapeutics SABS
NASDAQ SABS
$2.98 -0.08 (-2.61%)
As of: Oct 2, 2026 · 11:59 AM EDT

SAB Biotherapeutics (SABS) Change in Taxes (2022)

Updated

SAB Biotherapeutics' Change in Taxes was $92,281 in Q1 2022.

Analysis

SAB Biotherapeutics (SABS) Change in Taxes (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -2.22 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -1.53 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -131.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 171.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 SAB Biotherapeutics 264.67 Mn 264.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 92,281.00
API Access

SAB Biotherapeutics Change in Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-taxes&ticker=SABS&period=max&api_key=YOUR_API_KEY